Travere Therapeutics (TVTX) Free Cash Flow (QoQ) (2014 - 2026)
Travere Therapeutics (TVTX) Free Cash Flow (QoQ) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Travere Therapeutics |
5.07 Bn |
4.99 Bn |
102.38 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-166.52% |
| Dec 31, 2025 |
328.00% |
| Sep 30, 2025 |
184.51% |
| Jun 30, 2025 |
111.81% |
| Mar 31, 2025 |
-49.26% |
| Dec 31, 2024 |
33.50% |
| Sep 30, 2024 |
-5.14% |
| Jun 30, 2024 |
66.00% |
| Mar 31, 2024 |
-84.64% |
| Dec 31, 2023 |
41.76% |
| Sep 30, 2023 |
-113.61% |
| Jun 30, 2023 |
47.86% |
| Mar 31, 2023 |
-29.38% |
| Dec 31, 2022 |
16.62% |
| Sep 30, 2022 |
-149.92% |
| Jun 30, 2022 |
33.59% |
| Mar 31, 2022 |
37.33% |
| Dec 31, 2021 |
-378.98% |
| Sep 30, 2021 |
396.07% |
| Jun 30, 2021 |
120.64% |
